Clinical Trial Update: Moxonidine Effects on Neuropeptide Y [Phase 4]

View source ↗

Summary

Phase 4 trial updating the effects of moxonidine on neuropeptide Y in obesity and hypertension, completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension
• Obesity

Drugs mentioned

• Moxonidine (moxonidine)

Snippet

Sponsor: Aristotle University Of Thessaloniki | Conditions: Obesity, Hypertension | Phase 4 | Status: COMPLETED